RegenXBio stock forecast
RegenXBio (RB0) Stock Forecast & Price Target
RB0 Analyst Ratings
RB0 Stock 12 Month Forecast
Average Price Target
€18.84▲(163.83% Upside)Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Eliana Merle | Barclays | €10.81 | hold | 51.42%Upside | Reiterated | 11/06/26 | ||
| Alec Stranahan | Bank of America Securities | €13.52→€12.62 | buy | 76.65%Upside | Reiterated | 11/06/26 | ||
| Yi Chen | H.C. Wainwright | €18.92 | buy | 164.98%Upside | Reiterated | 11/06/26 | ||
| Brian Skorney | Robert W. Baird | €26.13→€22.53 | buy | 215.45%Upside | Reiterated | 11/06/26 | ||
| Graig Suvannavejh | Mizuho Securities | €17.12→€16.22 | buy | 127.12%Upside | Reiterated | 11/06/26 | ||
| Maxwell Skor | Morgan Stanley | €16.22 | buy | 127.12%Upside | Reiterated | 11/06/26 | ||
| Luca Issi | RBC Capital | €17.12 | buy | 139.74%Upside | Reiterated | 11/05/26 | ||
| Annabel Samimy | Stifel Nicolaus | €37.85 | buy | 429.96%Upside | Reiterated | 10/21/26 | ||
| Paul Choi | Goldman Sachs | €9.01 | hold | 26.18%Upside | Reiterated | 10/20/26 | ||
| Lili (Aurélie) Nsongo | Leerink Partners | €17.12 | buy | 139.74%Upside | Reiterated | 10/12/26 | ||
| Mara Goldstein | Clear Street | €40.55→€28.84 | buy | 303.78%Upside | Reiterated | 08/25/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Eliana MerleBarclays | HoldReiterated€10.81 | 11/06/26 | 51.42%Upside | ||
| Alec StranahanBank of America Securities | BuyReiterated€13.52→€12.62 | 11/06/26 | 76.65%Upside | ||
| Yi ChenH.C. Wainwright | BuyReiterated€18.92 | 11/06/26 | 164.98%Upside | ||
| Brian SkorneyRobert W. Baird | BuyReiterated€26.13→€22.53 | 11/06/26 | 215.45%Upside | ||
| Graig SuvannavejhMizuho Securities | BuyReiterated€17.12→€16.22 | 11/06/26 | 127.12%Upside | ||
| Maxwell SkorMorgan Stanley | BuyReiterated€16.22 | 11/06/26 | 127.12%Upside | ||
| Luca IssiRBC Capital | BuyReiterated€17.12 | 11/05/26 | 139.74%Upside | ||
| Annabel SamimyStifel Nicolaus | BuyReiterated€37.85 | 10/21/26 | 429.96%Upside | ||
| Paul ChoiGoldman Sachs | HoldReiterated€9.01 | 10/20/26 | 26.18%Upside | ||
| Lili (Aurélie) NsongoLeerink Partners | BuyReiterated€17.12 | 10/12/26 | 139.74%Upside | ||
| Mara GoldsteinClear Street | BuyReiterated€40.55→€28.84 | 08/25/26 | 303.78%Upside |
Best Analysts Covering RegenXBio
Copying Alec Stranahan's trades and holding each position for 3 Months would result in 45.83% of your transactions generating a profit, with an average return of +0.03% per trade.
Copying Luca Issi's trades and holding each position for 1 Year would result in 55.56% of your transactions generating a profit, with an average return of +5.34% per trade.
Copying Luca Issi's trades and holding each position for 2 Years would result in 44.44% of your transactions generating a profit, with an average return of -7.90% per trade.
RB0 Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 14 | 17 | 15 | 19 | 15 |
| Buy | 0 | 1 | 1 | 1 | 0 |
| Hold | 1 | 2 | 2 | 4 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 15 | 20 | 18 | 24 | 18 |
In the current month, RB0 has received 15 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. RB0 average Analyst price target in the past 3 months is 18.84.
RB0 Financial Forecast
RB0 Earnings Forecast
Next quarter’s earnings estimate for RB0 is -EUR 0.86 with a range of -EUR 1.68 to EUR 1.26. The previous quarter’s EPS was -EUR 0.56. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
RB0 Sales Forecast
Next quarter’s sales forecast for RB0 is EUR 25.35M with a range of EUR 5.91M to EUR 160.36M. The previous quarter’s sales results were EUR 8.20M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

